S13 Ep8: Oncology PER® Spectives: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma
OncLive® On Air
00:00
Safety Considerations in Intratumoral Oncolytic Immunotherapy
This chapter explores the safety aspects of intratumoral injections in oncolytic immunotherapies for melanoma, referencing findings from the IGNITE study. It assures listeners that adverse events are typically mild and emphasizes the importance of following standard safety practices to mitigate risks.
Transcript
Play full episode
